NSE · ANTHEM
Anthem Biosciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#202
of 5,072 stocks
▼ 61W
Peak #196 · 21 Sep 2026
Anthem Biosciences Limited, a largecap Healthcare business, remains firmly promoter-controlled, with promoters holding 71%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
49,217.31 Cr
P/E Ratio
41.40
P/B Ratio
16.13
ROE
19.45%
ROCE
27.57%
Dividend Yield
0.23%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 418.22 Cr | 610.94 Cr | 423.15 Cr | 550.03 Cr |
| Net Profit | 119.94 Cr | 189.76 Cr | 92.82 Cr | 173.43 Cr |
| EPS | 2.13 | 6.76 | 1.65 | 3.09 |
| Operating Profit | 145.47 Cr | 278.84 Cr | 156.20 Cr | 232.63 Cr |
Shareholding pattern
Promoter
71.42%
Public
28.58%
PUBLIC BREAKDOWN
FII
2.58%
DII
13.48%
MF (within DII)
11.15%
Individuals
9.45%
Mutual fund holdings
₹4,858.09
Cr total
140
Schemes
25
Fund Houses
₹4,858.09 Cr
Total Exposure
HDFC Mutual Fund₹1,144.62 Cr (23.6%)
SBI Mutual Fund₹888.75 Cr (18.3%)
Axis Mutual Fund₹684.55 Cr (14.1%)
UTI Mutual Fund₹369.21 Cr (7.6%)
Mahindra Manulife Mutual Fund₹350.51 Cr (7.2%)
Others₹1,420.45 Cr (29.2%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 25 Jun 2026 | Dividend | Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.